ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT HUMAN IL-2 (RHUIL-2) AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HIGH-RISK NEUROBLASTOMA (HR-NB)

Authors
PESSION A PRETE A LOCATELLI F ALVISI P GARAVENTA A MESSINA C PIERINELLI S BONETTI F CORDERO L FAVRE C ARRIGHINI A RONDELLI R DEBERNANDI B PAOLUCCI G
Citation
A. Pession et al., ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT HUMAN IL-2 (RHUIL-2) AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR HIGH-RISK NEUROBLASTOMA (HR-NB), Experimental hematology, 24(9), 1996, pp. 374-374
Citations number
NO
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
Experimental hematology → ACNP
ISSN journal
0301472X
Volume
24
Issue
9
Year of publication
1996
Pages
374 - 374
Database
ISI
SICI code
0301-472X(1996)24:9<374:AIWRHI>2.0.ZU;2-F